Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | SBC SBC Medical Group Holdings Incorporated | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $4.94 +2.1% | $16.31 +6.3% |
| StockIQ Score | 64C+ Moderate Risk: Medium | 42D Weak Risk: Medium |
| Technical | 74B | 36F |
| Fundamental | 86A | 35F |
| Growth | 56C | 50C- |
| Fair Value | 43D | 38F |
| News | 50C- | 50C- |
| Quality | 63C+ | 50C- |
| Risk | 46D+ | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
SBC Medical Group outperforms Ascentage Pharma in nearly every category. Its investor score (64 vs. 42) and fundamental score (86 vs. 35) are significantly stronger, indicating better stability and financial health. SBC also has a higher technical score (74 vs. 36), suggesting more favorable trading patterns. However, Ascentage Pharma’s growth score (50 vs. 56) is slightly better, though the overall rating (MODERATE vs. WEAK) still favors SBC.
